The company just raised $400M and is competing with Novartis and Merck to treat people with chronic myeloid leukemia.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
The company just raised $400M and is competing with Novartis and Merck to treat people with chronic myeloid leukemia.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Copyright © 2026 Biotech Networks